UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030105
Receipt number R000034366
Scientific Title Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG
Date of disclosure of the study information 2017/11/24
Last modified on 2023/07/25 11:36:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Acronym

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Scientific Title

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Scientific Title:Acronym

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Region

Japan


Condition

Condition

coronary artery bypass grafting

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

investigation for optimal dose of Landiolol Hydrochloride for on-pump beating-heart CABG

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

dose of landiolol and heart rate during on pump beating heart

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

dose of landiolol is not loaded, and increased every 10 minutes from 5 mcl/kg/min,15mcl/kg/min , 25 mcl/kg/min,35mcl/kg/min.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients scheduled for on-pump beating-heart technique CABG for surgical revascularization with general anesthesia

Key exclusion criteria

Patients who can not obtain informed consent
Patients judged inappropriate by the physician in charge of this study
Patients with atrial fibrillation

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name kawashima shingo

Organization

Hamamatsu University School of Medicine

Division name

Department of Anesthesiology and Intensive Care

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

0534352111

Email

shingogo@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name kawashima shingo

Organization

Hamamatsu University School of Medicine

Division name

Department of Anesthesiology and Intensive Care

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

0534352111

Homepage URL


Email

shingogo@hama-med.ac.jp


Sponsor or person

Institute

HAMAMATSU UNIVERSITY HOSPITAL

Institute

Department

Personal name



Funding Source

Organization

HAMAMATSU UNIVERSITY HOSPITAL

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 01 Day

Date of IRB

2011 Year 12 Month 01 Day

Anticipated trial start date

2017 Year 11 Month 01 Day

Last follow-up date

2018 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 24 Day

Last modified on

2023 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034366


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name